Tetrandrine in the Treatment of Rheumatoid Arthritis
Status:
Not yet recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of tetrandrine, compared with
placebo in 12 week or 24 week in RA patients with inadequate response to methotrexate.